Raymond James assumed coverage on shares of Guardian Pharmacy Services (NYSE:GRDN – Free Report) in a research note issued to investors on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $21.00 price target on the stock.
Separately, Truist Financial initiated coverage on shares of Guardian Pharmacy Services in a research note on Monday. They issued a “buy” rating and a $22.00 target price on the stock.
Get Our Latest Analysis on GRDN
Guardian Pharmacy Services Stock Performance
Insider Transactions at Guardian Pharmacy Services
In other news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of Guardian Pharmacy Services stock in a transaction dated Friday, September 27th. The shares were bought at an average cost of $14.00 per share, with a total value of $499,996.00. Following the completion of the transaction, the director now directly owns 35,714 shares in the company, valued at $499,996. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Hedge Funds Weigh In On Guardian Pharmacy Services
An institutional investor recently bought a new position in Guardian Pharmacy Services stock. Seven Grand Managers LLC bought a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 149,700 shares of the company’s stock, valued at approximately $2,515,000. Seven Grand Managers LLC owned 0.24% of Guardian Pharmacy Services as of its most recent filing with the SEC.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Stories
- Five stocks we like better than Guardian Pharmacy Services
- What is the Dogs of the Dow Strategy? Overview and Examples
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Quiet Period Expirations Explained
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.